Preferences help
enabled [disable] Abstract
Number of results
2011 | 6 | 4 | 407-410
Article title

Indapamide-induced hyponatremia or the syndrome of inappropriate antidiuretic hormone secretion: a case report

Title variants
Languages of publication
We report a case of an apparently well-documented indapamide-induced hyponatremia. The initial diagnosis was made on the basis of dechallenge and rechallenge performed on two occasions. Further course of the disease, which proved inconsistent with our expectations, prompted us to look for another aetiology leading to the final diagnosis of the syndrome of inappropriate antidiuretic hormone secretion (SIADH) complicated by indapamide treatment.
Physical description
1 - 8 - 2011
1 - 6 - 2011
  • NZOZ Pantamed Sp z o.o. w Olsztynie, ul. Pana Tadeusza 6, 10-461, Olsztyn, Poland
  • Medical Department, University of Warmia and Mazury in Olsztyn, ul. Żołnierska 14C, 10-900, Olsztyn, Poland
  • Cardiology and Internal Diseases Ward, City Complex of Hospitals in Olsztyn, ul. Niepodległości 44, 10-045, Olsztyn, Poland
  • Cardiology and Internal Diseases Ward, City Complex of Hospitals in Olsztyn, ul. Niepodległości 44, 10-045, Olsztyn, Poland
  • [1] Hannon M, Thompson C. SIADH: Prevalence, causes and consequences. Eur J Endocrinol. 2010; 162: S5–S12[Crossref]
  • [2] Adrogué HJ, Madias NE. Hyponatremia. N Engl J Med. 2000; 342(21):1581–1589[Crossref]
  • [3] Biswas M, Davies JS. Hyponatremia in clinical practice. Postgrad Med J. 2007 Jun;83(980):373–378. Witek P. Progress in diagnosis and treatment of hyponatremia. Postepy Nauk Medycznych 2008; (2): 75–82[Crossref]
  • [4] Gill G, Leese G. Hyponatremia: biochemical and clinical perspectives. Postgrad Med J. 1998; 74(875):516–523[Crossref]
  • [5] Krysiak R, Okopień B. Carbamazepine-induced hyponatremia. Pol. Arch. Med. Wew. 2007; 117: 193–195
  • [6] Verbalis JG, Drutarosky MD, Ertel RJ, Vollmer RR. Adaptive responses to sustained volume expansion in hyponatraemic rats. J Endocrinol. 1989; 122(1):421–431[Crossref]
  • [7] Morledge JH. Clinical efficacy and safety of indapamide in essential hypertension. Am Heart J. 1983; 106(1 Pt 2):229–232[Crossref]
  • [8] PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001; 358(9287):1033–1041[Crossref]
  • [9] Piotrowski W, Włodarczyk P, Jasiński B, Rywik S. Efficacy and Acceptability of the Indapamide SR 1,5 mg (Tertensif® SR) in Patients above 55 Years of Age with Isolated Systolic Hypertension - the STIP Study. Nadciśnienie Tętnicze. 2001; 5(4): 245–252
  • [10] Leonetti G. Clinical positioning of indapamide sustained release 1.5mg in management protocols for hypertension. Drugs. 2000;59(Suppl 2):27–38; discussion 39–40[Crossref]
  • [11] Kuo SW, Pei-Dee, Hung YJ, Hsieh AT, Wu LY, Hsieh CH, et al. Effect of indapamide SR in the treatment of hypertensive patients with type 2 diabetes. Am J Hypertens. 2003;16(8):623–628[Crossref]
  • [12] Chapman MD, Hanrahan R, McEwen J, Marley JE. Hyponatremia and hypokalaemia due to indapamide. Med J Aust. 2002; 176(5):219–221
  • [13] Hamano T, Yamamoto T, Miyamori I, Kuriyama M. Hyponatremia with somnolence due to indapamide. Rinsho Shinkeigaku. 2008;48(1):52–55 [PubMed][Crossref]
  • [14] Chan TY. Indapamide-induced severe hyponatremia and hypokalemia. Ann Pharmacother. 1995;29(11):1124–1128 [PubMed]
  • [15] Cabaj-Wiater I, Jakubowska I. Hyponatremia in Syndrome of Inappropiate Antidiuretic Hormone Secretion - cases report. Pol. Merk. Lek., 2008, 147: 247–249
  • [16] Howes L. Hyponatremia and hypokaliemia caused by indapamide. The medical Journal of Australia. 2002; 176(12): 53–54
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.